JOHBOC 日本遺伝性乳癌卵巣癌総合診療制度機構 | 編

【文献検索式リスト】

-2. 乳癌領域
-3. 卵巣癌領域
-4. 前立腺癌領域
-5. 膵癌領域
-6. 悪性黒色腫領域
-7. 疫学領域

 

-2. 乳癌領域

新CQ番号検索式検索DB
BQ1((Genetic Testing[Majr]) AND (Breast Neoplasms[Majr]) AND (brca[TW])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
(((((乳房腫瘍/TH) and (BRCA/AL) and (遺伝的サービス/TH))) and (DT=1994:2020 and PT=会議録除く))) and (PT=原著論文,総説)医中誌
BQ2((Mastectom*[TW] AND “nipple sparing”[TIAB]) AND (BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳輪/TA) or (乳頭/TA)))) and (DT=1994:2020 and PT=会議録除く)医中誌
BQ3(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (“Mammaplasty”[Mesh] OR “Breast Implants”[Mesh] OR “Organ Sparing Treatments”[Mesh] OR reconstruction*[TIAB])) AND (prophylactic[TW] OR risk-reducing[TIAB])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳房形成術/TH or 乳房再建/AL)))) and (DT=1994:2020 and PT=会議録除く)医中誌
CQ1((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((mastectomy[TW]) OR (surgery[TW])) AND ((risk-reducing[TIAB]) OR (prophylactic[TW]) OR (CRRM[TIAB])) AND (contralateral[TIAB])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (mastectomy):ti,ab,kw (Word variations have been searched)
#12 contralateral OR CRRM
#13 #10 AND #11 AND #12
Cochrane
((((((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳房切除術/TH or 乳房切除/AL)))) and (PT=会議録除く))) and (DT=1994:2020))) and (CK=ヒト)))医中誌
CQ2((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((mastectomy[TW]) OR (surgery[TW])) AND ((risk-reducing[TIAB]) OR (prophylactic[TW]) OR (BRRM[TIAB])) AND (bilateral[TIAB])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (mastectomy):ti,ab,kw (Word variations have been searched)
#12 bilateral OR BRRM
#13 #11 AND #12
#14 #13 NOT pubmed:an
Cochrane
((((((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳房切除術/TH or 乳房切除/AL)))) and (PT=会議録除く))) and (DT=1994:2020))) and (CK=ヒト)))医中誌
CQ3((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((“Mastectomy, Segmental”[Mesh]) OR ((conserv*[TIAB]) AND (surgery[TW])))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (mastectomy):ti,ab,kw (Word variations have been searched)
#12 segmental OR conserv*
#13 #10 AND #11 AND #12
Cochrane
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳房温存/AL) or ([乳房温存療法]/TH)))) and (DT=1994:2020 and PT=会議録除く)医中誌
CQ4、CQ5((((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((diagnostic imaging[SH]) OR (“Diagnostic Imaging”[Mesh])) AND ((surveillance[TIAB] OR screening[TW]) OR (“Early Diagnosis”[Mesh]))) AND ((risk[TW]) OR (sensitiv*[TIAB] OR sensitivity and specificity[MeSH]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]) AND (“Breast Neoplasms”[Mesh] OR “breast cancer”[TIAB])PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (surveillance):ti,ab,kw (Word variations have been searched)
#12 (screening):ti,ab,kw (Word variations have been searched)
#13 #11 or #12
#14 (‘magnetic resonance’ or MRI):ti,ab,kw (Word variations have been searched)
#15 mammmography or tomosynthesis or ultrasonography (Word variations have been searched)
#16 #14 or #15
#17 #10 and #13 and #16
#18 #17 with Publication Year from 1994 to 2020, in Trials
Cochrane
(((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and (((集団サーベイランス/TH or サーベイランス/AL)) or ((集団検診/TH or スクリーニング/AL)) or ((MRI/TH or MRI/AL))))) and (DT=1994:2020 and PT=会議録除く)) and ((乳房腫瘍/TH) and (SH=画像診断,X線診断,放射性核種診断,超音波診断))医中誌
CQ6((((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (“Ovariectomy”[Mesh] OR “Salpingo-oophorectomy”[Mesh] OR oophorectomy[TIAB])) AND (risk-reducing[TIAB] OR prophylactic[TIAB])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]) AND (risk[TW])PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (ovariectomy):ti,ab,kw (Word variations have been searched)
#12 (Salpingo-oophorectomy):ti,ab,kw (Word variations have been searched)
#13 RRSO
#14 #11 OR #12 OR #13
#15 #10 AND #14
Cochrane
((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and (((卵管卵巣摘出術/TH or 卵管卵巣摘出/AL)) or (RRSO/AL)))) and (PT=会議録除く))) and (DT=1994:2020)医中誌
CQ7(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (tamoxifen[TW])) AND ((“Chemoprevention”[Mesh] OR chemoprevent*[TIAB]) OR (prevent*[TW]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (tamoxifen):ti,ab,kw (Word variations have been searched)
#12 #10 AND #11
#13 chemoprevent* OR prevent*
#14 #12 AND #13
Cochrane
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((Tamoxifen/TH or タモキシフェン/AL)))) and (DT=1994:2020 and PT=会議録除く)医中誌
CQ8(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (“Platinum Compounds”[Mesh] OR platinum[TW] OR cisplatin[TW])) AND (advanced[TIAB] OR metastatic[TIAB] OR “Neoplasm Metastasis”[MH] OR “Neoplasm Recurrence, Local”[MH])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 advanced OR metasta*
#12 (platinum):ti,ab,kw (Word variations have been searched)
#13 (cisplatin):ti,ab,kw (Word variations have been searched)
#14 #12 OR #13
#15 #10 AND #11 AND #14
Cochrane
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and (((白金/TH or プラチナ/AL)) or (platinum/TA)))) and (DT=1994:2020 and PT=会議録除く)医中誌
CQ9((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (“Poly(ADP-ribose) Polymerase Inhibitors”[Mesh] OR “Poly(ADP-ribose) Polymerase Inhibitors” [Pharmacological Action]) AND (advanced[TIAB] OR metastatic[TIAB] OR “Neoplasm Metastasis”[MH] OR “Neoplasm Recurrence, Local”[MH])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 advanced OR metasta*
#12 (Polymerase):ti,ab,kw (Word variations have been searched)
#13 PARP-1
#14 #12 OR #13
#15 #10 AND #11 AND #14
Cochrane
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((“Poly (ADP-Ribose) Polymerase-1″/TH) or (PARP/TA)))) and (DT=1994:2020 and PT=会議録除く)医中誌
FQ1(((randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR clinical trials as topic[mesh:noexp] OR randomly[tiab] OR trial[ti] NOT (animals[mh] NOT humans[mh])) AND (((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (Chemotherapy, Adjuvant[Mesh])) OR ((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((Platinum Compounds[Mesh]) OR (“Poly(ADP-ribose) Polymerase Inhibitors”[Mesh] OR Poly ADP-ribose polymerase 1 inhibitor*[TIAB]) OR (denosumab[TW]) OR (checkpoint[TIAB]))))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH])PubMed
((((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL))))) and (SH=薬物療法))) and (DT=1994:2020 and PT=会議録除く))) and (PT=原著論文,総説)) or (((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL))))) and (SH=薬物療法))) and (DT=1994:2020 and PT=会議録除く)) and ((白金/TH) or (プラチナ/TA) or (“Poly (ADP-Ribose) Polymerase-1″/TH) or (免疫チェックポイント/TA) or (PARP/TA)))医中誌
FQ2(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (tamoxifen[TW])) AND ((“Chemoprevention”[Mesh] OR chemoprevent*[TIAB]) OR (prevent*[TW]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((化学予防/TH or 化学予防/AL)))) and (DT=1994:2020 and PT=会議録除く)医中誌
FQ3(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND (“Radiotherapy”[Mesh] OR “radiotherapy”[Subheading])) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]) AND (“Breast Neoplasms/radiotherapy”[Mesh]) AND mastectomy[TW]PubMed
((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL))))) and (SH=放射線療法)) or (((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((放射線療法/TH or 放射線療法/AL))))) and (DT=1994:2020 and PT=会議録除く)医中誌
FQ4((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((“Breast Self-Examination”[TW]) OR (“breast awareness”[TIAB]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
(((“breast awareness”/AL) or (((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((触診/TH or 触診/AL))))) and (PT=会議録除く)医中誌
FQ5(((BRCA*[TW] OR hereditary breast[TW] OR ((heredit*[tiab] OR inherit*[tiab] OR genet*[tiab] OR familial*[tiab] OR mutat*[tiab]) AND (breast cancer[tiab] OR Breast Neoplasms[MeSH]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((mastectomy[TW]) OR (surgery[TW])) AND ((risk-reducing[TIAB]) OR (prophylactic[TW]))) AND ((“Specimen Handling”[Mesh]) OR (occult[TIAB]) OR (Breast/pathology[MH] OR Breast Neoplasms/pathology[MH]))) AND (English[LA] OR Japanese[LA]) AND 1994/01[DP] : 2020/03[DP]PubMed
FQ6(((((((“mastectomy”[Text Word] OR “breast/surgery”[MeSH Terms]) OR ((“diagnostic imaging”[MeSH Subheading] OR “diagnostic imaging”[MeSH Terms]) AND ((“surveillance”[Title/Abstract] OR “screening”[Text Word]) OR “early diagnosis”[MeSH Terms]))) AND (“risk”[Text Word] OR (“sensitiv*”[Title/Abstract] OR “sensitivity and specificity”[MeSH Terms]))) OR (“prophylactic”[Text Word] OR “risk-reducing”[Title/Abstract])) OR “prevent*”[Text Word]) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]) AND (((((“brca*”[Text Word] OR “hereditary breast”[Text Word]) OR (((((“heredit*”[Title/Abstract] OR “inherit*”[Title/Abstract]) OR “genet*”[Title/Abstract]) OR “familial*”[Title/Abstract]) OR “mutat*”[Title/Abstract]) AND (“breast cancer”[Title/Abstract] OR “breast neoplasms”[MeSH Terms]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((“breast neoplasms, male”[MeSH Terms] OR “male breast cancer”[Title/Abstract]) OR “male”[Title])) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication])PubMed
#1 (BRCA):ti,ab,kw (Word variations have been searched)
#2 (heredit*):ti,ab,kw (Word variations have been searched)
#3 (inherit*):ti,ab,kw (Word variations have been searched)
#4 (genet*):ti,ab,kw (Word variations have been searched)
#5 (familial*):ti,ab,kw (Word variations have been searched)
#6 (mutat*):ti,ab,kw (Word variations have been searched)
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 (breast):ti,ab,kw (Word variations have been searched)
#9 (cancer):ti,ab,kw (Word variations have been searched)
#10 #7 AND #8 AND #9
#11 (male or man or med):ti,ab,kw
#12 #10 AND #11
#13 (screening or surveillance):ti,ab,kw (Word variations have been searched)
#14 (risk-reducing):ti,ab,kw (Word variations have been searched)
#15 (prophylactic):ti,ab,kw (Word variations have been searched)
#16 #13 or #14 or #15
#17 #12 and #16
#18 #17 not pubmed:an
#19 #18 with Publication Year from 1994 to 2020, in Trials
Cochrane
((((((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL))))) and (CK=男)) or (((遺伝性乳癌卵巣癌症候群/TH) or (((乳房腫瘍/TH or 乳癌/AL)) and ((遺伝性/AL) or (HBOC/AL) or (BRCA/AL)))) and ((乳房腫瘍-男性/TH or 男性乳癌/AL))))) and (PT=会議録除く)医中誌
全CQ(((((“Hereditary Breast and Ovarian Cancer Syndrome”[MeSH Terms] OR ((((“breast neoplasms/genetics”[MeSH Terms] OR “ovarian neoplasms/genetics”[MeSH Terms]) OR “breast cancer”[Title/Abstract]) OR “ovarian cancer”[Title/Abstract]) AND (((((“familial”[Title/Abstract] OR “inherit*”[Title/Abstract]) OR “heredit*”[Title/Abstract]) OR “predispos*”[Title/Abstract]) OR “susceptib*”[Title/Abstract]) OR “HBOC”[Title/Abstract]))) OR “brca*”[Text Word]) AND ((((((((((((((((((((((((((((“patient participation”[MeSH Terms] OR “community participation”[MeSH Terms]) OR “professional-patient relations”[MeSH Terms]) OR “patient-centered care”[MeSH Terms]) OR “patient preference”[MeSH Terms]) OR “patient satisfaction”[MeSH Major Topic]) OR “patient education as topic”[MeSH Terms]) OR “attitude to health”[MeSH Terms]) OR “attitude to death”[MeSH Terms]) OR “patient acceptance of health care”[MeSH Terms]) OR “health knowledge, attitudes, practice”[MeSH Terms]) OR “focus groups”[MeSH Terms]) OR “quality of life”[MeSH Major Topic]) OR “self care”[MeSH Terms:noexp]) OR “self concept”[MeSH Terms]) OR “self-examination”[MeSH Terms]) OR “cooperative behavior”[MeSH Terms]) OR “adaptation, psychological”[MeSH Terms]) OR “decision support techniques”[MeSH Terms]) OR “self-help groups”[MeSH Terms]) OR “community networks”[MeSH Terms]) OR “emotions”[MeSH Terms]) OR “consumer behavior”[MeSH Terms]) OR “needs assessment”[MeSH Terms]) OR “personal autonomy”[MeSH Terms]) OR “patient advocacy”[MeSH Terms]) OR “life change events”[MeSH Terms]) OR ((((((((((((((((((((((((((((((((((((“patient perspective*”[Title/Abstract] OR “patient s perspective*”[Title/Abstract]) OR “patient desire*”[Title/Abstract]) OR “patient s desire*”[Title/Abstract]) OR “patient’s desires”[Title/Abstract]) OR “patient view*”[Title/Abstract]) OR “patient s view*”[Title/Abstract]) OR “patient expression*”[Title/Abstract]) OR “patient s expression*”[Title/Abstract]) OR “patient attitude*”[Title/Abstract]) OR “patient s attitude*”[Title/Abstract]) OR “patient involvement*”[Title/Abstract]) OR “patient s involvement*”[Title/Abstract]) OR “patient decision*”[Title/Abstract]) OR “patient s decision*”[Title/Abstract]) OR “patient activation”[Title/Abstract]) OR “patient s activation”[Title/Abstract]) OR “patients activation”[Title/Abstract]) OR “patient empowerment”[Title/Abstract]) OR “patient participation”[Title/Abstract]) OR “patient s participation”[Title/Abstract]) OR “patients participation”[Title/Abstract]) OR “patient collaboration”[Title/Abstract]) OR “patient s collaboration”[Title/Abstract]) OR “patients collaboration”[Title/Abstract]) OR “expert patient*”[Title/Abstract]) OR “consumer participation”[Title/Abstract]) OR “consumer perspective”[Title/Abstract]) OR “consumers perspective”[Title/Abstract]) OR “consumer s perspective”[Title/Abstract]) OR “consumer involvement”[Title/Abstract]) OR “patient-focused”[Title/Abstract]) OR “patient-centred”[Title/Abstract]) OR “patient-centered”[Title/Abstract]) OR “patient needs”[Title/Abstract]) OR “self-management”[Title]) OR “self-perception”[Title/Abstract])) OR (“patients”[MeSH Major Topic] AND (“communication”[MeSH Terms] OR “decision making”[MeSH Terms])))) AND ((“clinical trial”[Publication Type] OR “meta-analysis”[Publication Type]) OR “systematic review”[Publication Type])) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
((((遺伝性乳癌卵巣癌症候群/TH) or (遺伝性乳/TA) or (HBOC/TA) or ((乳房腫瘍/TH) and (SH=遺伝学)) or ((卵巣腫瘍/TH) and (SH=遺伝学)) or (BRCA/AL)) and ((治療アドヒアランスとコンプライアンス/TH or 心理/AL or [臨床的判断]/TH or 社会心理学/TH or 患者の権利/TH or [生活の質]/TH)))) and (DT=1994:2020 and PT=会議録除く)医中誌
((((“Hereditary Breast and Ovarian Cancer Syndrome”[MeSH Terms] OR ((((“breast neoplasms/genetics”[MeSH Terms] OR “ovarian neoplasms/genetics”[MeSH Terms]) OR “breast cancer”[Title/Abstract]) OR “ovarian cancer”[Title/Abstract]) AND (((((“familial”[Title/Abstract] OR “inherit*”[Title/Abstract]) OR “heredit*”[Title/Abstract]) OR “predispos*”[Title/Abstract]) OR “susceptib*”[Title/Abstract]) OR “HBOC”[Title/Abstract]))) OR “brca*”[Text Word]) AND “Costs and Cost Analysis”[MeSH Terms]) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
((((((遺伝性乳癌卵巣癌症候群/TH) or (遺伝性乳/TA) or (HBOC/TA) or ((乳房腫瘍/TH) and (SH=遺伝学)) or ((卵巣腫瘍/TH) and (SH=遺伝学)) or (BRCA/AL)) and ((経済学/TH or 診療報酬/TH or 診療報酬/AL or 医療費/TH or 費用/AL)))) and (PT=会議録除く))) and (DT=1994:2020)医中誌

-3. 卵巣癌領域

新CQ番号検索式検索DB
BQ1   #1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“ovarian neoplasms”[ Majr] OR (“ovarian”[Title] AND “neoplasms”[Title])) OR “ovarian neoplasms”[Title]) OR (“ovarian”[Title] AND “cancer”[Title])) OR “ovarian cancer”[Title]
#3 Search: “genetic testing”[MeSH Terms] OR (“genetic”[TIAB] AND “testing”[TIAB]) OR “genetic testing”[TIAB]
#4 Search: #1 and #2 and #3
#5 Search: #4 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la])
#6 Search: #5 NOT (Animals[MH] NOT Humans[MH])
#7 Search: (((“mutation rate”[MeSH Terms] OR (“mutation”[All Fields] AND “rate”[All Fields])) OR “mutation rate”[All Fields]) OR (“mutation”[All Fields] AND “frequency”[All Fields])) OR “mutation frequency”[All Fields]
#8 Search: (((((((((“epidemiology”[MeSH Subheading] OR “epidemiology”[All Fields]) OR “prevalence”[All Fields]) OR “prevalence”[MeSH Terms]) OR “prevalance”[All Fields]) OR “prevalences”[All Fields]) OR “prevalence s”[All Fields]) OR “prevalent”[All Fields]) OR “prevalently”[All Fields]) OR “prevalents”[All Fields]) OR ((((((((((((((“pathogen”[All Fields] OR “pathogen s”[All Fields]) OR “pathogene”[All Fields]) OR “pathogenes”[All Fields]) OR “pathogenic”[All Fields]) OR “pathogenically”[All Fields]) OR “pathogenicities”[All Fields]) OR “pathogenicity”[MeSH Subheading]) OR “pathogenicity”[All Fields]) OR “virulence”[MeSH Terms]) OR “virulence”[All Fields]) OR “pathogenity”[All Fields]) OR “pathogenous”[All Fields]) OR “pathogens”[All Fields]) AND ((“variant”[All Fields] OR “variant s”[All Fields]) OR “variants”[All Fields]))
#9 Search: #7 OR #8
#10 Search: #6 AND #9
#11 Search: “criteria s”[All Fields] OR “criterias”[All Fields] OR “standards”[MeSH Subheading] OR “standards”[All Fields] OR “criteria”[All Fields]
#12 Search: #6 AND #11
#13 Search: #10 AND #12
PubMed
BQ1#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “ovarian neoplasms”] or (ovarian cancer):ti,ab,kw
#3 [mh “genetic testing”] or (genetic testing):ti,ab,kw
#4 #1 and #2 and #3 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#5 criteria:ti,ab,kw
#6 #4 and #5 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
BQ1#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 卵巣腫瘍/TH or卵巣癌/AL or 卵巣がん/AL or 遺伝性乳癌卵巣癌症候群/TH
#3 遺伝学的検査/TH or 遺伝学的検査/AL or 遺伝子検査/AL or 遺伝子スクリーニング/AL or 遺伝学的検査/AL or 遺伝学的スクリーニング/AL
#4 #1 and #2 and #3
#5 #4 and (DT=1994/1/1:2020/3/31)
#6 (#5) and (LA=日本語,英語 CK=ヒト)
#7 (#6) and (PT=会議録除く)
#8 #7 and ((RD=診療ガイドライン) or 診療ガイドライン/MTH or ガイドライン/TI)
#9 #7 and ((RD=メタアナリシス) or システマティックレビュー/TH or メタアナリシス/TH or メタアナリシス/TI or システマティックレビュー/TI or システマティック・レビュー/TI)
#10 #7 and ((RD=ランダム化比較試験) or RCT/TI or (RD=準ランダム化比較試験) or (RD=比較研究) or 比較研究/TI)
医中誌
BQ2#1 BRCA[tiab] OR “Genes, BRCA1″[mh] OR “Genes, BRCA2″[mh] OR BRCA1[tw] OR BRCA2[tw] OR Mutation[mh] OR mutation[tiab] OR mutations[tiab] OR mutational[tiab]
#2 RRSO[tiab] OR Risk Reducing Salpingo-oophorectomy[tw] OR “Salpingo-Oophorectomy”[mh] OR “Prophylactic Surgical Procedures”[mh]
#3 surgery[tiab] OR surgical[tiab] OR standard[tiab] OR standardized[tiab] OR protocol[tiab] OR protocols[tiab] OR method[tiab] OR methods[tiab] OR treatment[tiab]
#4 (#1 AND #2 AND #3) AND (English[la] OR Japanese[la]) NOT (Animals[mh] NOT Humans[mh]) AND (1994/01[dp]:2020/03[dp])
PubMed
BQ2#1 (“rrso” or “risk-reducing salpingo-oophorectomy”):ti,ab,kw
#2 #1 in Cochrane Reviews
#3 #1 in Trials
Cochrane
BQ2#1 BRCA/TA or BRCA1遺伝子/TH or BRCA2遺伝子/TH or 変異/TA or 変異/TH
#2 RRSO/TA or リスク低減/TA or 卵巣摘出/TA or 卵巣摘出術/TH or 卵管摘出/TA or 卵管摘出術/TH or 予防的手術/TH
#3 術式/TA or 手術/TA#4 (#1 and #2 and #3) and (PT=会議録除く and CK=ヒト) and ((PDAT=1994/1/1:2020/3/31) or (IDAT=1994/1/1:2020/3/31)) and (DT=1994:2020)
医中誌
BQ3#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB]
#3 Search: “early detection of cancer”[MeSH Terms] OR (“early”[All Fields] AND “detection”[All Fields] AND “cancer”[All Fields]) OR “early detection of cancer”[All Fields] OR “screening”[TIAB]
#4 Search: “epidemiology”[MeSH Subheading] OR “epidemiology”[TIAB] OR “surveillance”[TIAB] OR “epidemiology”[MeSH Terms] OR “surveilance”[TIAB] OR “surveillances”[TIAB] OR “surveilled”[TIAB] OR “surveillence”[TIAB]
#6 Search: (BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]) AND ((((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB])
#7 Search: (“early detection of cancer”[MeSH Terms] OR (“early”[All Fields] AND “detection”[All Fields] AND “cancer”[All Fields]) OR “early detection of cancer”[All Fields] OR “screening”[TIAB]) OR (“epidemiology”[MeSH Subheading] OR “epidemiology”[TIAB] OR “surveillance”[TIAB] OR “epidemiology”[MeSH Terms] OR “surveilance”[TIAB] OR “surveillances”[TIAB] OR “surveilled”[TIAB] OR “surveillence”[TIAB])
#8 Search: ((BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]) AND ((((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB])) AND ((“early detection of cancer”[MeSH Terms] OR (“early”[All Fields] AND “detection”[All Fields] AND “cancer”[All Fields]) OR “early detection of cancer”[All Fields] OR “screening”[TIAB]) OR (“epidemiology”[MeSH Subheading] OR “epidemiology”[TIAB] OR “surveillance”[TIAB] OR “epidemiology”[MeSH Terms] OR “surveilance”[TIAB] OR “surveillances”[TIAB] OR “surveilled”[TIAB] OR “surveillence”[TIAB]))
#9 Search: ((BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]) AND ((((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB])) AND ((“early detection of cancer”[MeSH Terms] OR (“early”[All Fields] AND “detection”[All Fields] AND “cancer”[All Fields]) OR “early detection of cancer”[All Fields] OR “screening”[TIAB]) OR (“epidemiology”[MeSH Subheading] OR “epidemiology”[TIAB] OR “surveillance”[TIAB] OR “epidemiology”[MeSH Terms] OR “surveilance”[TIAB] OR “surveillances”[TIAB] OR “surveilled”[TIAB] OR “surveillence”[TIAB])) AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#10 Search: ((“ca-125 antigen”[MeSH Terms] OR (“ca 125″[All Fields] AND “antigen”[All Fields])) OR “ca 125 antigen”[All Fields]) OR “ca 125″[All Fields] OR “ca125” [All Fields]
#11 Search: (“diagnostic imaging”[MeSH Subheading] OR “diagnostic imaging”[MeSH Terms]) OR “imaging”[All Fields]
#12 Search: “sonograph*”[All Fields] OR “ultrasonography”[MeSH Terms] OR “ultrasonography”[All Fields] OR “ultrasound*”[All Fields] OR “ultrasonics”[MeSH Terms] OR “ultrasonic*”[All Fields] OR “echograph*”[All Fields]
#13 Search: (((“tomography, x-ray computed”[MeSH Terms] OR ((“tomography”[All Fields] AND “x ray”[All Fields]) AND “computed”[All Fields])) OR “x-ray computed tomography”[All Fields]) OR (“computed”[All Fields] AND “tomography”[All Fields])) OR “computed tomography”[All Fields]
#14 Search: (((“positron emission tomography computed tomography”[MeSH Terms] OR ((((“positron”[All Fields] AND “emission”[All Fields]) AND “tomography”[All Fields]) AND “computed”[All Fields]) AND “tomography”[All Fields])) OR “positron emission tomography computed tomography”[All Fields]) OR (“pet”[All Fields] AND “ct”[All Fields])) OR “pet ct”[All Fields]
#15 Search: ((((((“ca-125 antigen”[MeSH Terms] OR (“ca 125″[All Fields] AND “antigen”[All Fields])) OR “ca 125 antigen”[All Fields]) OR “ca 125″[All Fields] OR “ca125” [All Fields]) OR ((“diagnostic imaging”[MeSH Subheading] OR “diagnostic imaging”[MeSH Terms]) OR “imaging”[All Fields])) OR (“sonograph*”[All Fields] OR “ultrasonography”[MeSH Terms] OR “ultrasonography”[All Fields] OR “ultrasound*”[All Fields] OR “ultrasonics”[MeSH Terms] OR “ultrasonic*”[All Fields] OR “echograph*”[All Fields])) OR ((((“tomography, x-ray computed”[MeSH Terms] OR ((“tomography”[All Fields] AND “x ray”[All Fields]) AND “computed”[All Fields])) OR “x-ray computed tomography”[All Fields]) OR (“computed”[All Fields] AND “tomography”[All Fields])) OR “computed tomography”[All Fields])) OR ((((“positron emission tomography computed tomography”[MeSH Terms] OR ((((“positron”[All Fields] AND “emission”[All Fields]) AND “tomography”[All Fields]) AND “computed”[All Fields]) AND “tomography”[All Fields])) OR “positron emission tomography computed tomography”[All Fields]) OR (“pet”[All Fields] AND “ct”[All Fields])) OR “pet ct”[All Fields])
#16 Search: (((BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]) AND ((((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB])) AND ((“early detection of cancer”[MeSH Terms] OR (“early”[All Fields] AND “detection”[All Fields] AND “cancer”[All Fields]) OR “early detection of cancer”[All Fields] OR “screening”[TIAB]) OR (“epidemiology”[MeSH Subheading] OR “epidemiology”[TIAB] OR “surveillance”[TIAB] OR “epidemiology”[MeSH Terms] OR “surveilance”[TIAB] OR “surveillances”[TIAB] OR “surveilled”[TIAB] OR “surveillence”[TIAB])) AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])) AND (((((((“ca-125 antigen”[MeSH Terms] OR (“ca 125″[All Fields] AND “antigen”[All Fields])) OR “ca 125 antigen”[All Fields]) OR “ca 125″[All Fields] OR “ca125” [All Fields]) OR ((“diagnostic imaging”[MeSH Subheading] OR “diagnostic imaging”[MeSH Terms]) OR “imaging”[All Fields])) OR (“sonograph*”[All Fields] OR “ultrasonography”[MeSH Terms] OR “ultrasonography”[All Fields] OR “ultrasound*”[All Fields] OR “ultrasonics”[MeSH Terms] OR “ultrasonic*”[All Fields] OR “echograph*”[All Fields])) OR ((((“tomography, x-ray computed”[MeSH Terms] OR ((“tomography”[All Fields] AND “x ray”[All Fields]) AND “computed”[All Fields])) OR “x-ray computed tomography”[All Fields]) OR (“computed”[All Fields] AND “tomography”[All Fields])) OR “computed tomography”[All Fields])) OR ((((“positron emission tomography computed tomography”[MeSH Terms] OR ((((“positron”[All Fields] AND “emission”[All Fields]) AND “tomography”[All Fields]) AND “computed”[All Fields]) AND “tomography”[All Fields])) OR “positron emission tomography computed tomography”[All Fields]) OR (“pet”[All Fields] AND “ct”[All Fields])) OR “pet ct”[All Fields]))
PubMed
BQ3#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “ovarian neoplasms”] or (ovarian cancer):ti,ab,kw
#3 [mh “early detection of cancer”] or (early detection cancer):ti,ab,kw or (screening):ti,ab,kw or [mh “epidemiology”] or (epidemiology):ti,ab,kw or (surveillance*):ti,ab,kw
#4 #1 and #2 and #3 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#5 [mh “ca-125 antigen”] or (ca125):ti,ab,kw
#6 [mh “diagnostic imaging”] or (imaging):ti,ab,kw
#7 [mh “ultrasonography”] or (ultrasound*):ti,ab,kw or (echograph*):ti,ab,kw
#8 [mh “tomography, x-ray computed”] or (x ray):ti,ab,kw
#9 [mh “positron emission tomography computed tomography”] or (positron emission tomography):ti,ab,kw or (computed tomography):ti,ab,kw or (“pet ct”):ti,ab,kw
#10 #5 or #6 or #7 or #8 or #9
#11 #4 and #10 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
BQ3#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 卵巣腫瘍/TH or 卵巣癌/AL or 卵巣がん/AL or 遺伝性乳癌卵巣癌症候群/TH
#3 CA-125抗原/TH or CA125/AL or CA-125/AL
#4 画像診断/TH or 画像診断法/AL or 医用画像/AL or 画像診断/AL
#5 超音波診断/TH or 超音波画像/AL or 超音波検査/AL or 超音波所見/AL or 超音波診断/AL
#6 (X線CT/TH or CT/AL) or (陽電子放射型断層撮影/TH or PET/AL) or (PET-CT検査/TH or PET-CT検査/AL or PET-CT/AL)
#7 #1 and #2 and #3
#8 #4 or #5 or #6
#9 #1 and #2 and #8
#10 #3 and #9
#11 #7 and (DT=1994/1/1:2020/3/31)
#12 (#11) and (PT=原著論文,総説)
#13 #9 and (DT=1994/1/1:2020/3/31)
#14 (#13) and (LA=日本語,英語 CK=ヒト)
#15 (#11) and (LA=日本語,英語 CK=ヒト)
#16 (#14) and (PT=会議録除く)
#17 (#14) and (PT=原著論文,総説)
#18 #16 and #15
医中誌
CQ1#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (“risk”[MeSH Terms] OR “risk”[All Fields]) AND (((“reduce”[All Fields] OR “reduced”[All Fields]) OR “reduces”[All Fields]) OR “reducing”[All Fields]) AND (((“salpingo-oophorectomy”[MeSH Terms] OR “salpingo oophorectomy”[All Fields]) OR (“salpingo”[All Fields] AND “oophorectomy”[All Fields])) OR “salpingo oophorectomy”[All Fields]) OR “RRSO”[All Fields]
#3 Search: (“primary prevention”[MeSH Terms] OR (“primary”[All Fields] AND “prevention”[All Fields])) OR “primary prevention”[All Fields] OR (“risk factors”[MeSH Terms] OR (“risk”[All Fields] AND “factors”[All Fields])) OR “risk factors”[All Fields]
#4 Search: #1 and #2 and #3
#5 Search: #4 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#6 Search: #5 AND (“Cochrane Database Syst Rev”[TA] OR “Meta-Analysis”[PT] OR “Practice Guideline”[PT] OR “Guideline”[PT] OR “Guidelines as Topic”[MH] OR Review[PT] OR meta-analysis[TIAB] OR guideline*[TI] OR “systematic review”[TIAB] OR review[TI] OR overview[TI])
#7 Search: #5 AND (“Clinical Trials as Topic”[Mesh] OR “Clinical Trial” [PT] OR ((clinical trial* OR clinical stud* OR random* OR controlled trial*) NOT medline[SB]))
#8 Search: #5 AND (“Research Design”[Mesh] OR ” Epidemiologic Study Characteristics “[Mesh] OR “Study Characteristics” [PT] OR ((cohort* OR comparative stud*) NOT medline[SB]))
PubMed
CQ1#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 (([mh risk] or (risk):ti,ab,kw) and (reduce*):ti,ab,kw and ([mh “salpingo-oophorectomy”] or (salpingo oophorectomy):ti,ab,kw)) or (RRSO):ti,ab,kw
#3 [mh “primary prevention”] or (primary prevention):ti,ab,kw or [mh “risk factors”] or (risk factors):ti,ab,kw
#4 #1 and #2 and #3 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#5 [mh “genetic counseling”] or (genetic counseling):ti,ab,kw
#6 #1 and #2 and #5 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
CQ1#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 (((卵管/TH or 卵管/AL) or (卵巣/TH or 卵巣/AL)) and (予防的手術/TH or リスク低減手術/AL or 予防手術/AL or 予防的切除/AL or (リスク低減/AL and 摘出/AL))) or RRSO/AL
#3 (遺伝相談/TH or 遺伝カウンセリング/AL) or (カウンセラー/AL or カウンセリング/AL) and (遺伝的/AL or 遺伝/AL)
#4 病因/AL
#5 (医療費/TH or 費用/AL or 医療費/AL)
#6 (患者の好み/TH or 患者の意向/AL)
#7 #1 and #2
#8 (#7 and (DT=1994/1/1:2020/3/31)) and (LA=日本語,英語 PT=会議録除く CK=ヒト)
#9 #8 and ((RD=診療ガイドライン) or 診療ガイドライン/MTH or ガイドライン/TI)
#10 #8 and ((RD=メタアナリシス) or システマティックレビュー/TH or メタアナリシス/TH or メタアナリシス/TI or システマティックレビュー/TI or システマティック・レビュー/TI)
#11 #8 and ((RD=ランダム化比較試験) or RCT/TI or (RD=準ランダム化比較試験) or (RD=比較研究) or 比較研究/TI)
#12 #1 and #2 and (#3 or #4 or #5 or #6)
#13 (#12 and (DT=1994/1/1:2020/3/31)) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
#14 #13 and ((RD=診療ガイドライン) or 診療ガイドライン/MTH or ガイドライン/TI)
医中誌
CQ2PRSO × SEE-Fim
#1 RRSO[tiab] OR Risk Reducing Salpingo-oophorectomy[tw] OR “Salpingo-Oophorectomy”[mh] OR “Prophylactic Surgical Procedures”[mh]
#2 “SEE-FIM”[tiab] OR (pathologial examination[tw] AND fallopian tube[tw]) OR “Fallopian Tubes/pathology”[mh]
#3 #1 AND #2 AND (English[la] OR Japanese[la]) NOT (Animals[mh] NOT Humans[mh]) AND (1994/01[dp]:2020/03[dp])
BRCA × SEE-Fim
#1 BRCA[tiab] OR “Genes, BRCA1″[mh] OR “Genes, BRCA2″[mh]
#2 “SEE-FIM”[tiab] OR (pathologial examination[tw] AND fallopian tube[tw]) OR “Fallopian Tubes/pathology”[mh]
#3 #1 AND #2 AND (English[la] OR Japanese[la]) NOT (Animals[mh] NOT Humans[mh]) AND (1994/01[dp]:2020/03[dp])
PubMed
CQ2#1 (“rrso” or “risk-reducing salpingo-oophorectomy”):ti,ab,kw
#2 #1 in Cochrane Review
s
#3 #1 in Trials
Cochrane
CQ2#1 BRCA/TA or BRCA1遺伝子/TH or BRCA2遺伝子/TH or オカルト癌/TA or 不顕性癌/TH or 不顕性癌/TH
#2 RRSO/TA or リスク低減/TA or 卵管卵巣摘出/TA or 卵管摘出/TA or 卵管摘出術/TH or 予防的手術/TH
#3 ((卵管/TH) and (SH=病理学)) or SEE-FIM/TA or ((卵管/TA) and ((病理検査/TA or 病理学/TA)))
#4 (#1 and #3) and (PT=会議録除く and CK=ヒト) and ((PDAT=1994/1/1:2020/3/31) or (IDAT=1994/1/1:2020/3/31)) and (DT=1994:2020)
#4′ (#2 and #3) and (PT=会議録除く and CK=ヒト) and ((PDAT=1994/1/1:2020/3/31) or (IDAT=1994/1/1:2020/3/31)) and (DT=1994:2020)
#4” (#1 and #2 and #3) and (PT=会議録除く and CK=ヒト) and ((PDAT=1994/1/1:2020/3/31) or (IDAT=1994/1/1:2020/3/31)) and (DT=1994:2020)
医中誌
CQ3#1 Search: BRCA*[All Fields] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[ALL FIELDS] AND “neoplasms”[Title])) OR “ovarian neoplasms”[ALL FIELDS]) OR (“ovarian”[ALL FIELDS] AND “cancer”[ALL FIELDS])) OR “ovarian cancer”[ALL FIELDS]
#3 Search: “chemotherapy”[ALL FIELDS] OR “drug therapy”[MeSH Terms] OR (“drug”[ALL FIELDS] AND “therapy”[ALL FIELDS]) OR “drug therapy”[ALL FIELDS] OR “chemotherapies”[ALL FIELDS] OR “drug therapy”[MeSH Subheading] OR “pharmacotherapy”[ALL FIELDS]
#4 Search: (((((((“health care costs”[MeSH Terms] OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost*”[All Fields])) OR “health care cost*”[All Fields]) OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost”[All Fields])) OR “health care cost”[All Fields]) OR “treatment cost*”[All Fields]) OR “healthcare cost*”[All Fields]) OR “medical care cost*”[All Fields]) OR (((((“economics”[MeSH Subheading] OR “economics”[All Fields]) OR “cost”[All Fields]) OR “costs and cost analysis”[MeSH Terms]) OR ((“costs”[All Fields] AND “cost”[All Fields]) AND “analysis”[All Fields])) OR “costs and cost analysis”[All Fields])
#5 Search: ”patient preference”[MeSH Terms] OR (“patient”[All Fields] AND “preference”[All Fields]) OR “patient preference”[All Fields]
#6 Search: (“treatment outcome”[MeSH Terms] OR (“treatment”[TIAB] AND “outcome”[TIAB])) OR “treatment outcome”[TIAB]
#7 Search: #1 and #2 and #3
#8 Search: #4 OR #5
#9 Search: #7 and #8
#10 Search: #9 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#11 Search: BRCA*[Title] or “Genes, BRCA1”[Majr] or “Genes, BRCA2”[Majr] or “BRCA1 Protein”[Majr] or “BRCA2 Protein”[Majr]
#12 Search: (((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[Title] AND “neoplasms”[Title])) OR “ovarian neoplasms”[Title]) OR (“ovarian”[Title] AND “cancer”[Title])) OR “ovarian cancer”[Title]
#13 Search: “chemotherapy”[TIAB] OR “drug therapy”[MeSH Terms] OR (“drug”[TIAB] AND “therapy”[TIAB]) OR “drug therapy”[TIAB] OR “chemotherapies”[TIAB] OR “drug therapy”[MeSH Subheading] OR “pharmacotherapy”[TIAB]
#14 Search: (((((((“health care costs”[MeSH Terms] OR ((“health”[TIAB] AND “care”[TIAB]) AND “cost*”[TIAB])) OR “health care cost*”[TIAB]) OR ((“health”[TIAB] AND “care”[TIAB]) AND “cost”[TIAB])) OR “health care cost”[TIAB]) OR “treatment cost*”[TIAB]) OR “healthcare cost*”[TIAB]) OR “medical care cost*”[TIAB]) OR (((((“economics”[MeSH Subheading] OR “economics”[TIAB]) OR “cost”[TIAB]) OR “costs and cost analysis”[MeSH Terms]) OR ((“costs”[TIAB] AND “cost”[TIAB]) AND “analysis”[TIAB])) OR “costs and cost analysis”[TIAB])
#15 Search: ”patient preference”[MeSH Terms] OR (“patient”[TIAB] AND “preference”[TIAB]) OR “patient preference”[TIAB]
#16 Search: #11 and #12 and #13 and (#14 or #15 or #6)
#17 Search: #21 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
PubMed
CQ3#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”] 
#2 [mh “ovarian neoplasms”] or (ovarian cancer):ti,ab,kw 
#3 [mh “drug therapy”] or (pharmacotherapy):ti,ab,kw or (chemotherap*):ti,ab,kw or (“drug therapy”):ti,ab,kw 
#4 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw 
#5 [mh “patient preference”] or (patient preference):ti,ab,kw 
#6 [mh “treatment outcome”] or (treatment outcome):ti,ab,kw 
#7 #1 and #2 and #3 
#8 #4 or #5 or #6 
#9 #7 and #8 with Cochrane Library publication date from Jan 1994 to Mar 2020Limits 
#10 #7 and (#4 or #5) with Cochrane Library publication date from Jan 1994 to Mar 2020
Cochrane
CQ3#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 卵巣腫瘍/TH or 卵巣癌/AL or 卵巣がん/AL or 遺伝性乳癌卵巣癌症候群/TH
#3 薬物療法/TH or 薬物療法/AL or 化学療法/AL or 投薬/AL or 薬物治療/AL or 与薬/AL
#4 医療費/TH or 費用/AL or 医療費/AL
#5 患者の好み/TH or 患者の意向/AL
#6 #1 and #2 and #3
#7 #4 or #5
#8 #6 and #7
#9 (#6 and (DT=1994/1/1:2020/3/31)) and (LA=日本語,英語 PT=会議録除く CK=ヒト)
#10 (#9) and (PT=原著論文,総説)
#11 #9 and ((RD=診療ガイドライン) or 診療ガイドライン/MTH or ガイドライン/TI)
#12 #9 and ((RD=メタアナリシス) or システマティックレビュー/TH or メタアナリシス/TH or メタアナリシス/TI or システマティックレビュー/TI or システマティック・レビュー/TI)
#13 #9 and ((RD=ランダム化比較試験) or RCT/TI or (RD=準ランダム化比較試験) or (RD=比較研究) or 比較研究/TI)
医中誌
CQ4#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[Title])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB]
#3 Search: ((((“poly adp ribose polymerase inhibitors”[Pharmacological Action] OR “poly adp-ribose polymerase inhibitors”[MeSH Terms]) OR ((“poly adp ribose”[TIAB] AND “polymerase”[TIAB]) AND “inhibitors”[TIAB])) OR “poly adp ribose polymerase inhibitors”[TIAB]) OR (“PARP”[TIAB] AND “inhibitor”[TIAB])) OR “PARP inhibitor”[TIAB]
#4 Search: (((“maintenance”[MeSH Terms] OR “maintenance”[TIAB]) OR “maintenances”[TIAB]) AND ((((“drug therapy”[MeSH Subheading] OR (“drug”[TIAB] AND “therapy”[TIAB])) OR “drug therapy”[TIAB]) OR “drug therapy”[MeSH Terms]) OR (“drug”[TIAB] AND “therapy”[TIAB]))) OR ((“maintenance chemotherapy”[MeSH Terms] OR (“maintenance”[TIAB] AND “chemotherapy”[TIAB])) OR “maintenance chemotherapy”[TIAB])
#5 Search: (((((((“health care costs”[MeSH Terms] OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost*”[All Fields])) OR “health care cost*”[All Fields]) OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost”[All Fields])) OR “health care cost”[All Fields]) OR “treatment cost*”[All Fields]) OR “healthcare cost*”[All Fields]) OR “medical care cost*”[All Fields]) OR (((((“economics”[MeSH Subheading] OR “economics”[All Fields]) OR “cost”[All Fields]) OR “costs and cost analysis”[MeSH Terms]) OR ((“costs”[All Fields] AND “cost”[All Fields]) AND “analysis”[All Fields])) OR “costs and cost analysis”[All Fields])
#6 Search: ”patient preference”[MeSH Terms] OR (“patient”[All Fields] AND “preference”[All Fields]) OR “patient preference”[All Fields]
#7 Search: #1 and #2 and #3 and #4
#8 Search: #7 and (#5 or #6)
#9 Search: #8 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#10 Search: #7 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
PubMed
CQ4#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “ovarian neoplasms”] or (ovarian cancer):ti,ab,kw
#3 [mh “poly adp-ribose polymerase inhibitors”] or (“poly adp ribose polymerase inhibitors”):ti,ab,kw or (“PARP inhibitor”):ti,ab,kw
#4 [mh “maintenance”] or (maintenance*):ti,ab,kw
#5 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw
#6 [mh “patient preference”] or (patient preference):ti,ab,kw
#7 #1 and #2 and #3 and #4 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#8 #5 or #6
#9 #7 and #8 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
CQ4#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 卵巣腫瘍/TH or 卵巣癌/AL or 卵巣がん/AL or 遺伝性乳癌卵巣癌症候群/TH
#3 (“Poly(ADP-ribose) Polymerase Inhibitors”/TH or PARP阻害剤/AL or PARP抑制剤/AL) or ((“Poly(ADP-Ribose) Polymerases”/TH or PARP/AL) and ((思考途絶/TH or 阻害/AL) or (“抑制(心理学)”/TH or 抑制/AL)))
#4 (寛解維持療法/TH or 維持療法/AL or 寛解維持療法/AL or 薬物維持療法/AL)
#5 (医療費/TH or 費用/AL or 医療費/AL)
#6 (患者の好み/TH or 患者の意向/AL)
#7 #1 and #2 and #3 and #4
#8 #1 and #2 and #3 and #4 and (#5 or #6)
#9 (#7 and (DT=1994/1/1:2020/3/31)) and (LA=日本語,英語 PT=会議録除く CK=ヒト)
医中誌
CQ5#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (BRCA*[TIAB] and mutation*[TIAB] and carrier*[TIAB]) AND (“breast neoplasms”[MeSH Terms] OR (“breast”[TIAB] AND “neoplasms”[TIAB]) OR “breast neoplasms”[TIAB] OR (“breast”[TIAB] AND “cancer”[TIAB]) OR “breast cancer”[TIAB] OR “ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB]) OR “ovarian neoplasms”[TIAB] OR (“ovarian”[TIAB] AND “cancer”[TIAB]) OR “ovarian cancer”[TIAB]) OR (“hereditary breast and ovarian cancer syndrome”[MeSH Terms] OR “hereditary breast and ovarian cancer syndrome”[TIAB] OR “HBOC”[TIAB])
#3 Search: “contraceptives, oral”[MeSH Terms] OR (“contraceptives”[TIAB] AND “oral”[TIAB]) OR “oral contraceptives”[TIAB] OR (“oral”[TIAB] AND “contraceptives”[TIAB])
#4 Search: “risk reduction behavior”[MeSH Terms] OR (“risk”[TIAB] AND “reduction”[TIAB] AND “behavior”[TIAB]) OR “risk reduction behavior”[TIAB] OR (“risk”[TIAB] AND “reduction”[TIAB]) OR “risk reduction”[TIAB] OR “adaptation, psychological”[MeSH Terms] OR (“adaptation”[TIAB] AND “psychological”[TIAB]) OR “psychological adaptation”[TIAB] OR (“risk”[TIAB] AND “reduction”[TIAB])
#5 Search: “drug-related side effects and adverse reactions”[MeSH Terms] OR “drug related side effects and adverse reactions”[All Fields] OR “adverse effects”[MeSH Subheading] OR (“adverse”[All Fields] AND “effect*”[All Fields]) OR “adverse effect*”[All Fields] OR (“side”[All Fields] AND “effect*”[All Fields]) OR “side effect*”[All Fields]
#6 Search: (((“health care costs”[MeSH Terms] OR ((“health”[All Fields] AND “care”[All Fields]) AND “costs”[All Fields])) OR “health care costs”[All Fields]) OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost”[All Fields])) OR “health care cost”[All Fields]
#7 Search: (“patient preference”[MeSH Terms] OR (“patient”[All Fields] AND “preference”[All Fields])) OR “patient preference”[All Fields]
#8 Search: #1 and #2 and #3
#9 Search: #4 or #5 or #6 or #7
#10 Search: #8 and #9
#11 Search: #8 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#12 Search: #10 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
PubMed
CQ5#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “hereditary breast and ovarian cancer syndrome”] or (HBOC):ti,ab,kw or [mh “ovarian neoplasms”] or [mh “breast neoplasms”] or (breast cancer):ti,ab,kw or (ovarian cancer):ti,ab,kw
#3 [mh “contraceptives, oral”] or (oral contraceptive*):ti,ab,kw
#4 [mh “risk reduction behavior”] or (risk reduction behavior):ti,ab,kw or (risk reduction):ti,ab,kw or [mh “adaptation, psychological”] or (psychological adaptation);ti,ab,kw
#5 [mh “drug-related side effects and adverse reactions”] or (side effect*):ti,ab,kw or (adverse effect*):ti,ab,kw or [mh “ovarian neoplasms”/AE] or [mh “breast neoplasms”/AE]
#6 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw
#7 [mh “patient preference”] or (patient preference):ti,ab,kw
#8 “#1 and #2 and #3with Cochrane Library publication date Between Jan 1994 and Mar 2020”
#9 #4 or #5 or #6 or #7
#10 #8 and #9
Cochrane
CQ5#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 遺伝性乳癌卵巣癌症候群/TH or 遺伝性乳癌卵巣癌症候群/AL or HBOC/AL or 卵巣腫瘍/TH and or卵巣癌/AL or 卵巣がん/AL or 乳房腫瘍/TH or 乳癌/AL or 乳がん/AL or 乳房癌/AL or 乳腺癌/AL or 乳腺がん/AL
#3 低用量/AL and (経口避妊剤/TH or 経口避妊薬/AL or (経口/AL and 避妊/AL))
#4 #1 and #2 and #3
#5 #4 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
#6 #1 and #2 and (経口避妊剤/TH or 経口避妊薬/AL or (経口/AL and 避妊/AL))
#7 #6 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
医中誌
CQ6#1 Search: BRCA*[All Fields] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: “HRT”[All Fields] OR ((“hormone replacement therapy”[MeSH Terms] OR ((“hormone”[All Fields] AND “replacement”[All Fields]) AND “therapy”[All Fields])) OR “hormone replacement therapy”[All Fields]) OR ((“oestrogen replacement therapy”[All Fields] OR “estrogen replacement therapy”[MeSH Terms]) OR ((“estrogen”[All Fields] AND “replacement”[All Fields]) AND “therapy”[All Fields])) OR “estrogen replacement therapy”[All Fields]
#3 Search: “drug-related side effects and adverse reactions”[MeSH Terms] OR “drug related side effects and adverse reactions”[All Fields] OR “adverse effects”[MeSH Subheading] OR (“adverse”[All Fields] AND “effect*”[All Fields]) OR “adverse effect*”[All Fields] OR (“side”[All Fields] AND “effect*”[All Fields]) OR “side effect*”[All Fields]
#4 Search: (((((((“health care costs”[MeSH Terms] OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost*”[All Fields])) OR “health care cost*”[All Fields]) OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost”[All Fields])) OR “health care cost”[All Fields]) OR “treatment cost*”[All Fields]) OR “healthcare cost*”[All Fields]) OR “medical care cost*”[All Fields]) OR (((((“economics”[MeSH Subheading] OR “economics”[All Fields]) OR “cost”[All Fields]) OR “costs and cost analysis”[MeSH Terms]) OR ((“costs”[All Fields] AND “cost”[All Fields]) AND “analysis”[All Fields])) OR “costs and cost analysis”[All Fields])
#5 Search: (“patient preference”[MeSH Terms] OR (“patient”[All Fields] AND “preference”[All Fields])) OR “patient preference”[All Fields]
#6 Search: “QOL”[All Fields] OR ((“quality of life”[MeSH Terms] OR (“quality”[All Fields] AND “life”[All Fields])) OR “quality of life”[All Fields])
#7 Search: (((“breast neoplasms”[MeSH Terms] OR (“breast”[All Fields] AND “neoplasms”[All Fields])) OR “breast neoplasms”[All Fields]) OR (“breast”[All Fields] AND “cancer”[All Fields])) OR “breast cancer”[All Fields]
#8 Search: #1 and #2
#9 Search: #3 or #4 or #5 or #6
#10 Search: #8 and #9
#11 Search: #10 and #7
#12 Search: #11 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
PubMed
CQ6#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “hormone replacement therapy”] or (HRT):ti,ab,kw or (oestrogen replacement therapy):ti,ab,kw or (hormone replacement therapy):ti,ab,kw or (estrogen replacement therapy):ti,ab,kw
#3 #1 and #2 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#4 [mh “drug-related side effects and adverse reactions”] or (side effect*):ti,ab,kw or (adverse effect*):ti,ab,kw or [mh “ovarian neoplasms”/AE] or [mh “breast neoplasms”/AE] with Cochrane Library publication date Between Jan 1994 and Mar 2020
#5 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw
#6 [mh “patient preference”] or (patient preference):ti,ab,kw
#7 [mh “quality of life”] or (“quality of life”):ti,ab,kw or (QOL):ti,ab,kw
#8 [mh “breast neoplasms”] or (breast cancer):ti,ab,kw
#9 #3 and (#4 or # 5 or #6 or #7) with Cochrane Library publication date Between Jan 1994 and Mar 2020
#10 #9 and #8
Cochrane
CQ6#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 ホルモン補充療法/TH or エストロゲン代償療法/TH and ホルモン補充療法/AL or ホルモン代償療法/AL or ホルモン補充/AL or HRT/AL
#3 医薬品副作用と有害反応/TH or 副作用/AL or 有害反応/AL or 有害作用or/AL and 毒性/AL or 薬物反応/AL
#4 (医療費/TH or 費用/AL)
#5 (患者の好み/TH or 患者の意向/AL)
#6 (生活の質/TH or QOL/AL) or (生活の質/TH or 生活の質/AL)
#7 (乳房腫瘍/TH or 乳癌/AL)
#8 #3 or #4 or #5 or #6
#9 #1 and #2 and #8
#10 #9 and (DT=1994/1/1:2020/3/31)
#11 (#10) and (LA=日本語,英語 PT=会議録除く CK=ヒト)
#12 #1 and #2
#13 #12 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
#14 #2 and #7 and #8
#15 #14 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
#16 (#15) and (PT=原著論文,総説)
医中誌
FQ1#1 RRSO[tiab] OR Risk Reducing Salpingo-oophorectomy[tw] OR “Salpingo-Oophorectomy”[mh] OR “Prophylactic Surgical Procedures”[mh]
#2 “Peritoneal Neoplasms”[mh] OR peritoneal carcinomatosis[tiab] OR peritoneal carcinomatoses[tiab] OR peritonial carcinoma[tiab]
#3 (#1 AND #2) AND (English[la] OR Japanese[la]) NOT (Animals[mh] NOT Humans[mh]) AND (1994/01[dp]:2020/03[dp])
PubMed
FQ1#1 (“rrso” or “risk-reducing salpingo-oophorectomy”):ti,ab,kw
#2 #1 in Cochrane Reviews
#3 #1 in Trials
Cochrane
FQ1#1 RRSO/TA or リスク低減/TA or 卵巣摘出/TA or 卵巣摘出術/TH or 卵管摘出/TA or 卵管摘出術/TH or 予防的手術/TH
#2 腹膜癌/TA or 腹膜腫瘍/TH
#3 サーベイランス/TA or 観察/TA or 診断/TA or 超音波/TA or PET-CA/TA or 画像診断/TH
#4 (#1 and #2 and #3) and (PT=会議録除く and CK=ヒト) and ((PDAT=1994/1/1:2020/3/31) or (IDAT=1994/1/1:2020/3/31)) and (DT=1994:2020)
医中誌
FQ2#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[TIAB] AND “neoplasms”[TIAB])) OR “ovarian neoplasms”[TIAB]) OR (“ovarian”[TIAB] AND “cancer”[TIAB])) OR “ovarian cancer”[TIAB]
#3 Search: (((“fertility preservation”[MeSH Terms] OR (“fertility”[All Fields] AND “preservation”[All Fields])) OR “fertility preservation”[All Fields]) and ((“organ sparing treatments”[MeSH Terms] OR ((“organ”[All Fields] AND “sparing”[All Fields]) AND “treatment*”[All Fields])) OR “organ sparing treatment*”[All Fields] )) or (((((“fertiles”[All Fields] OR “fertility”[MeSH Terms]) OR “fertility”[All Fields]) OR “fertile”[All Fields]) OR “fertilities”[All Fields]) AND (((“spare”[All Fields] OR “spared”[All Fields]) OR “spares”[All Fields]) OR “sparing”[All Fields]) AND ((((((((((“surgery”[MeSH Subheading] OR “surgery”[All Fields]) OR “surgical procedures, operative”[MeSH Terms]) OR ((“surgical”[All Fields] AND “procedures”[All Fields]) AND “operative”[All Fields])) OR “operative surgical procedures”[All Fields]) OR “general surgery”[MeSH Terms]) OR (“general”[All Fields] AND “surgery”[All Fields])) OR “general surgery”[All Fields]) OR “surgery s”[All Fields]) OR “surgerys”[All Fields]) OR “surgeries”[All Fields]))
#4 Search: (“pregnancy outcome”[MeSH Terms] OR (“pregnancy”[All Fields] AND “outcome*”[All Fields])) OR “pregnancy outcome*”[All Fields]
#5 Search: (((“breast neoplasms”[MeSH Terms] OR (“breast”[All Fields] AND “neoplasms”[All Fields])) OR “breast neoplasms”[All Fields]) OR (“breast”[All Fields] AND “cancer”[All Fields])) OR “breast cancer”[All Fields]
#6 Search: ((“ovarian”[All Fields] OR “ovarians”[All Fields]) AND (((((((((((((((((((“functional”[All Fields] OR “functional s”[All Fields]) OR “functionalities”[All Fields]) OR “functionality”[All Fields]) OR “functionalization”[All Fields]) OR “functionalizations”[All Fields]) OR “functionalize”[All Fields]) OR “functionalized”[All Fields]) OR “functionalizes”[All Fields]) OR “functionalizing”[All Fields]) OR “functionally”[All Fields]) OR “functionals”[All Fields]) OR “functioned”[All Fields]) OR “functioning”[All Fields]) OR “functionings”[All Fields]) OR “functions”[All Fields]) OR “physiology”[MeSH Subheading]) OR “physiology”[All Fields]) OR “function”[All Fields]) OR “physiology”[MeSH Terms])) or ((((“ovarian function tests”[MeSH Terms] OR ((“ovarian”[All Fields] AND “function”[All Fields]) AND “tests”[All Fields])) OR “ovarian function tests”[All Fields]) OR ((“ovarian”[All Fields] AND “function”[All Fields]) AND “test”[All Fields])) OR “ovarian function test”[All Fields])
#7 Search: #1 and #2 and #3
#8 Search: #7 and (#4 or #5 or #6)
#9 Search: #8 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#10 Search: #7 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#11 Search: #2 and #3
#12 Search: #11 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#13 Search: #4 or #5 or #6
#14 Search: #13 and #11
#15 Search: #12 AND (“Cochrane Database Syst Rev”[TA] OR “Meta-Analysis”[PT] OR “Practice Guideline”[PT] OR “Guideline”[PT] OR “Guidelines as Topic”[MH] OR Review[PT] OR meta-analysis[TIAB] OR guideline*[TI] OR “systematic review”[TIAB] OR review[TI] OR overview[TI])
#16 Search: #12 AND (“Clinical Trials as Topic”[Mesh] OR “Clinical Trial” [PT] OR ((clinical trial* OR clinical stud* OR random* OR controlled trial*) NOT medline[SB]))
#17 Search: #12 AND (“Research Design”[Mesh] OR ” Epidemiologic Study Characteristics “[Mesh] OR “Study Characteristics” [PT] OR ((cohort* OR comparative stud*) NOT medline[SB]))
PubMed
FQ2#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “salpingectomy”] or (salpingectomy*):ti,ab,kw or [mh “ovariectomy”] or (ovariectom*):ti,ab,kw or (oophorectom*):ti,ab,kw
#3 ([mh “risk reduction behavior”] or (risk reduction behavior):ti,ab,kw or ((risk reduction) and (suger*)):ti,ab,kw or (RRS):ti,ab,kw) or ((([mh “risk”] or (risk):ti,ab,kw) and (reduce*):ti,ab,kw and ([mh “salpingo-oophorectomy”] or (salpingo oophorectomy):ti,ab,kw)) or (RRSO):ti,ab,kw)
#4 [mh “genetic counseling”] or (genetic counseling):ti,ab,kw
#5 [mh “etiology”] or (etiolog*):ti,ab,kw or (pathogenesis):ti,ab,kw
#6 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw
#7 [mh “patient preference”] or (patient preference):ti,ab,kw
#8 #1 and #2 and #3
#9 #4 or #5 or #6 or #7
#10 #8 and #9 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#11 #2 and #3 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
FQ2#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 (卵管/TH or 卵管/AL) and (予防的手術/TH or リスク低減手術/AL or 予防手術/AL or 予防的切除/AL)
#3 (遺伝相談/TH or 遺伝カウンセリング/AL) or (カウンセラー/AL or カウンセリング/AL) and (遺伝的/AL or 遺伝/AL)
#4 病因/AL
#5 医療費/TH or 費用/AL or 医療費/AL
#6 患者の好み/TH or 患者の意向/AL
#7 #1 and #2
#8 #3 or #4 or #5 or #6
#9 #7 and #8
#10 #9 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
医中誌
FQ3#1 Search: BRCA*[TIAB] or “Genes, BRCA1”[MeSH Terms] or “Genes, BRCA2”[MeSH Terms] or “BRCA1 Protein”[MeSH Terms] or “BRCA2 Protein”[MeSH Terms]
#2 Search: (((“salpingectomy”[MeSH Terms] OR “salpingectomy”[TIAB] OR “salpingectomies”[TIAB]) AND (“ovariectomy”[MeSH Terms] OR “ovariectomy”[TIAB] OR “oophorectomies”[TIAB] OR “oophorectomy”[TIAB]))) OR “PSDO” [TIAB]
#3 Search: (((((((((“risk reduction behavior”[MeSH Terms] OR ((“risk”[TIAB] AND “reduction”[TIAB]) AND “behavior”[TIAB])) OR “risk reduction behavior”[TIAB]) OR (“risk”[TIAB] AND “reduction”[TIAB])) OR “risk reduction”[TIAB]) OR “adaptation, psychological”[MeSH Terms]) OR (“adaptation”[TIAB] AND “psychological”[TIAB])) OR “psychological adaptation”[TIAB]) OR (“risk”[TIAB] AND “reduction”[TIAB])) AND ((((((((((“surgery”[MeSH Subheading] OR “surgery”[TIAB]) OR “surgical procedures, operative”[MeSH Terms]) OR ((“surgical”[TIAB] AND “procedures”[TIAB]) AND “operative”[TIAB])) OR “operative surgical procedures”[TIAB]) OR “general surgery”[MeSH Terms]) OR (“general”[TIAB] AND “surgery”[TIAB])) OR “general surgery”[TIAB]) OR “surgery s”[TIAB]) OR “surgerys”[TIAB]) OR “surgeries”[TIAB]) OR “RRS”[TIAB]) OR ((“risk”[MeSH Terms] OR “risk”[TIAB]) AND (((“reduce”[TIAB] OR “reduced”[TIAB]) OR “reduces”[TIAB]) OR “reducing”[TIAB]) AND (((“salpingo-oophorectomy”[MeSH Terms] OR “salpingo oophorectomy”[TIAB]) OR (“salpingo”[TIAB] AND “oophorectomy”[TIAB])) OR “salpingo oophorectomy”[TIAB]) OR “RRSO”[TIAB])
#4 Search: ((“genetic counselling”[All Fields] OR “genetic counseling”[MeSH Terms]) OR (“genetic”[All Fields] AND “counseling”[All Fields])) OR “genetic counseling”[All Fields] OR (“prenatal”[All Fields] AND “genetic”[All Fields] AND “counseling”[All Fields]) OR “prenatal genetic counseling”[All Fields]
#5 Search: “etiology”[MeSH Subheading] OR “etiology”[All Fields] OR “pathogenesis”[All Fields]
#6 Search: (((((((“health care costs”[MeSH Terms] OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost*”[All Fields])) OR “health care cost*”[All Fields]) OR ((“health”[All Fields] AND “care”[All Fields]) AND “cost”[All Fields])) OR “health care cost”[All Fields]) OR “treatment cost*”[All Fields]) OR “healthcare cost*”[All Fields]) OR “medical care cost*”[All Fields]) OR (((((“economics”[MeSH Subheading] OR “economics”[All Fields]) OR “cost”[All Fields]) OR “costs and cost analysis”[MeSH Terms]) OR ((“costs”[All Fields] AND “cost”[All Fields]) AND “analysis”[All Fields])) OR “costs and cost analysis”[All Fields])
#7 Search: (“patient preference”[MeSH Terms] OR (“patient”[All Fields] AND “preference”[All Fields])) OR “patient preference”[All Fields]
#8 Search: #1 and #2 and #3
#9 Search: #4 or #5 or #6 or #7
#10 Search: #8 and #9
#11 Search: #10 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#12 Search: #2 and #3 AND (1994/01[DP]:2020/03[DP]) AND (English[la] or japanese[la]) NOT (Animals[MH] NOT Humans[MH])
#13 Search: #12 and #1
#14 Search: #12 NOT #13
PubMed
FQ3#1 (BRCA*):ti,ab,kw or [mh “Genes, BRCA1”] or [mh “Genes, BRCA2”] or [mh “BRCA1 Protein”] or [mh “BRCA2 Protein”]
#2 [mh “salpingectomy”] or (salpingectomy*):ti,ab,kw or [mh “ovariectomy”] or (ovariectom*):ti,ab,kw or (oophorectom*):ti,ab,kw
#3 ([mh “risk reduction behavior”] or (risk reduction behavior):ti,ab,kw or ((risk reduction) and (suger*)):ti,ab,kw or (RRS):ti,ab,kw) or ((([mh “risk”] or (risk):ti,ab,kw) and (reduce*):ti,ab,kw and ([mh “salpingo-oophorectomy”] or (salpingo oophorectomy):ti,ab,kw)) or (RRSO):ti,ab,kw)
#4 [mh “genetic counseling”] or (genetic counseling):ti,ab,kw
#5 [mh “etiology”] or (etiolog*):ti,ab,kw or (pathogenesis):ti,ab,kw
#6 [mh “health care costs”] or [mh “costs and cost analysis”] or (cost):ti,ab,kw
#7 [mh “patient preference”] or (patient preference):ti,ab,kw
#8 #1 and #2 and #3
#9 #4 or #5 or #6 or #7
#10 #8 and #9 with Cochrane Library publication date Between Jan 1994 and Mar 2020
#11 #2 and #3 with Cochrane Library publication date Between Jan 1994 and Mar 2020
Cochrane
FQ3#1 (BRCA1遺伝子/TH or BRCA1遺伝子/AL) or (BRCA2遺伝子/TH or BRCA2遺伝子/AL) or BRCA/AL or 乳癌遺伝子/AL
#2 (卵管/TH or 卵管/AL) and (予防的手術/TH or リスク低減手術/AL or 予防手術/AL or 予防的切除/AL)
#3 (遺伝相談/TH or 遺伝カウンセリング/AL) or (カウンセラー/AL or カウンセリング/AL) and (遺伝的/AL or 遺伝/AL)
#4 病因/AL
#5 医療費/TH or 費用/AL or 医療費/AL
#6 患者の好み/TH or 患者の意向/AL
#7 #1 and #2
#8 #3 or #4 or #5 or #6
#9 #7 and #8
#10 #9 and (DT=1994/1/1:2020/3/31) and (LA=日本語,英語 and PT=会議録除く and CK=ヒト)
医中誌

-4. 前立腺癌領域

新CQ番号検索式検索DB
CQ1   (((((“brca*”[Text Word] OR ((“germ-line mutation”[MeSH Terms] OR “germline”[Title/Abstract]) OR “germ-line”[Title/Abstract])) OR “neoplastic syndromes, hereditary”[MeSH Terms]) AND (“prostate cancer”[Title/Abstract] OR “prostatic neoplasms”[MeSH Terms])) AND (((“prostate-specific antigen”[MeSH Terms] OR “psa”[Title/Abstract]) OR “magnetic resonance imaging”[MeSH Terms]) OR (“surveillance”[Title/Abstract] OR “screening”[Title/Abstract]))) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
#1 遺伝性乳癌卵巣癌症候群/TA or (腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL) or HBOC/TA or BRCA/AL or 生殖細胞系変異/TH
#2 前立腺腫瘍/TH or 前立腺癌/TA
#3 #1 and #2
#4 (前立腺特異抗原/TH or PSA/AL)
#5 #1 and #4
#6 (集団検診/TH or スクリーニング/AL)
#7 (集団サーベイランス/TH or サーベイランス/AL)
#8 #6 or #7
#9 #3 and #8
#10 #5 or #9
#11 (#10) and (PT=会議録除く)
医中誌
FQ1(((((“brca*”[Text Word] OR ((“germ-line mutation”[MeSH Terms] OR “germline”[Title/Abstract]) OR “germ-line”[Title/Abstract])) OR “neoplastic syndromes, hereditary”[MeSH Terms]) AND (“prostate cancer”[Title/Abstract] OR “prostatic neoplasms”[MeSH Terms])) AND ((“Genetic Testing”[MeSH Terms] OR ((“genetic test”[Title/Abstract] OR “Genetic Testing”[Title/Abstract]) OR “genetic screening”[Title/Abstract])) OR “family history”[Title/Abstract])) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((前立腺腫瘍/TH or 前立腺癌/TA) and (((遺伝学的検査/TH or 遺伝学的検査/AL)) or (BRCA/AL) or (生殖細胞系変異/TH) or (lynch/AL)))) and (PT=会議録除く and CK=ヒト)医中誌
FQ2((((((“brca*”[Text Word] OR ((“germ-line mutation”[MeSH Terms] OR “germline”[Title/Abstract]) OR “germ-line”[Title/Abstract])) OR “neoplastic syndromes, hereditary”[MeSH Terms]) AND (“prostate cancer”[Title/Abstract] OR “prostatic neoplasms”[MeSH Terms])) AND (“Therapeutics”[MeSH Terms] OR “therapy”[MeSH Subheading])) AND (((((((((“randomized controlled trial”[Publication Type] OR “controlled clinical trial”[Publication Type]) OR “randomized”[Title/Abstract]) OR “placebo”[Title/Abstract]) OR “drug therapy”[MeSH Subheading]) OR “randomly”[Title/Abstract]) OR “trial”[Title/Abstract]) OR “groups”[Title/Abstract]) NOT (“animals”[MeSH Terms] NOT “humans”[MeSH Terms])) OR (“systematic”[Filter] OR “meta-analysis”[Publication Type]))) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((((前立腺腫瘍/TH or 前立腺癌/TA) and ((BRCA/AL) or (生殖細胞系変異/TH) or (腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL)))) and (PT=会議録除く))) and (DT=1994:2020)医中誌

-5. 膵癌領域

新CQ番号検索式検索DB
CQ1   (((((((“Pancreatic Neoplasms”[MeSH Terms] OR “pancreatic cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) OR “pancreatic neoplasms/genetics”[MeSH Terms]) AND “drug therapy”[MeSH Subheading]) AND (((((((“randomized controlled trial”[Publication Type] OR “controlled clinical trial”[Publication Type]) OR “randomized”[Title/Abstract]) OR “placebo”[Title/Abstract]) OR “clinical trials as topic”[MeSH Terms:noexp]) OR “randomly”[Title/Abstract]) OR “trial”[Title]) NOT (“animals”[MeSH Terms] NOT “humans”[MeSH Terms]))) OR (((((“Pancreatic Neoplasms”[MeSH Terms] OR “pancreatic cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) OR “pancreatic neoplasms/genetics”[MeSH Terms]) AND “drug therapy”[MeSH Subheading]) AND (“systematic”[Filter] OR “meta-analysis”[Publication Type]))) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((((((((膵臓腫瘍/TH or 膵臓癌/AL)) and (遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH))) and (SH=薬物療法)) or ((((膵臓腫瘍/TH or 膵臓癌/AL)) and (遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH)) and ((“Poly(ADP-ribose) Polymerase Inhibitors”/TH) or (PARP/TA) or (白金化合物/TH))))) and (DT=1994:2020 and PT=会議録除く and CK=ヒト))) and (PT=原著論文,総説)医中誌
FQ1(((((“Pancreatic Neoplasms”[MeSH Terms] OR “pancreatic cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) OR “pancreatic neoplasms/genetics”[MeSH Terms]) AND “genetic testing”[MeSH Terms]) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
((膵臓腫瘍/TH or 膵臓癌/AL)) and ((遺伝学的検査/TH or 遺伝学的検査/AL)) and ((BRCA/AL) or (生殖細胞系変異/TH))医中誌
FQ2((((“Pancreatic Neoplasms”[MeSH Terms] OR “pancreatic cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) OR “pancreatic neoplasms/genetics”[MeSH Terms]) AND (“screening”[Title/Abstract] OR “surveillance”[Title/Abstract])) AND “diagnostic imaging”[MeSH Terms]PubMed
((((((膵臓腫瘍/TH or 膵臓癌/AL)) and (遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH) and (((集団検診/TH or スクリーニング/AL)) or ((集団サーベイランス/TH or サーベイランス/AL)) or ((画像診断/TH or 画像診断/AL))))) and (DT=1994:2020 and PT=会議録除く and CK=ヒト))) and (PT=原著論文,総説)医中誌

-6. 悪性黒色腫領域

新CQ番号検索式検索DB
FQ1   (((“melanoma”[MeSH Terms] OR “melanoma”[Title/Abstract]) AND “brca*”[Text Word]) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((((((((黒色腫/TH or 悪性黒色腫/AL)) or (メラノーマ/TA)) and (遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH))) and (PT=会議録除く and CK=ヒト))) and (PT=原著論文,総説))) and (DT=1994:2020)医中誌

-7. 疫学領域

新CQ番号検索式検索DB
FQ1   (((((“breast neoplasms”[MeSH Terms] OR “breast cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((((((“Smoking”[MeSH Terms] OR “Alcohol Drinking”[MeSH Terms]) OR “Body Mass Index”[MeSH Terms]) OR “Pregnancy”[MeSH Terms]) OR “contraceptives, oral”[MeSH Terms]) OR “Exercise”[MeSH Terms]) OR “Food”[MeSH Terms])) AND (“Epidemiologic Studies”[MeSH Terms] OR (“systematic”[Filter] OR “meta-analysis”[Publication Type]))) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((((遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH) and ((食行動/TH or 食生活/AL) or (ライフスタイル/TH or 生活習慣/AL) or (タバコ喫煙/TH or 喫煙/AL) or (Alcohols/TH) or (BMI/TH or BMI/AL) or ((身体運動/TH or 運動/AL)) or ((飲酒/TH or 飲酒/AL)) or ([疫学要因]/TH) or ((妊娠/TH or 妊娠/AL)) or ((授乳/TH or 授乳/AL)) or ((避妊剤/TH or 避妊薬/AL))) and ((乳房腫瘍/TH or 乳癌/AL)))) and (DT=1994:2020 and PT=会議録除く and CK=ヒト))) and (PT=原著論文,総説)医中誌
FQ2((((“ovarian neoplasms”[MeSH Terms] OR “ovarian cancer”[Title/Abstract]) AND ((“brca*”[Text Word] OR “Mutation”[Text Word]) OR “neoplastic syndromes, hereditary”[MeSH Terms])) AND ((((((“Smoking”[MeSH Terms] OR “Alcohol Drinking”[MeSH Terms]) OR “Body Mass Index”[MeSH Terms]) OR “Pregnancy”[MeSH Terms]) OR “contraceptives, oral”[MeSH Terms]) OR “Exercise”[MeSH Terms]) OR “Food”[MeSH Terms])) AND (“English”[Language] OR “Japanese”[Language])) AND 1994/1/1:2020/3/31[Date – Publication]PubMed
(((((遺伝性乳癌卵巣癌症候群/TA or 腫瘍症候群-遺伝性/TH or 遺伝性腫瘍症候群/AL or HBOC/TA or BRCA/AL or 変異/TH) and ((食行動/TH or 食生活/AL) or (ライフスタイル/TH or 生活習慣/AL) or (タバコ喫煙/TH or 喫煙/AL) or (Alcohols/TH) or (BMI/TH or BMI/AL) or ((身体運動/TH or 運動/AL)) or ((飲酒/TH or 飲酒/AL)) or ([疫学要因]/TH) or ((妊娠/TH or 妊娠/AL)) or ((授乳/TH or 授乳/AL)) or ((避妊剤/TH or 避妊薬/AL))) and ((卵巣腫瘍/TH or 卵巣癌/AL)))) and (DT=1994:2020 and PT=会議録除く and CK=ヒト))) and (PT=原著論文,総説)医中誌

このホームページは厚生労働科学研究費補助金(がん対策推進総合研究事業)「ゲノム情報を活用した遺伝性腫瘍の先制的医療提供体制の整備に関する研究」(代表:櫻井晃洋)により作成致しました。